Skip to main content
Clinical Trials/ACTRN12617001180303
ACTRN12617001180303
Completed
Phase 2

Abdominal Functional Electrical Stimulation To Assist Ventilator Weaning In Critically Ill Patients

euroscience Research Australia0 sites20 target enrollmentAugust 11, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
euroscience Research Australia
Enrollment
20
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 11, 2017
End Date
May 1, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
euroscience Research Australia

Eligibility Criteria

Inclusion Criteria

  • mechanical ventilation dependence due to critical illness

Exclusion Criteria

  • expected to be ventilated for \< 24 hours (based on clinical judgement)
  • ventilated for \> 72 hours (to avoid excessive muscle atrophy)
  • non\-pharmacological paralysis (e.g. spinal cord injury or Guillain\-Barré syndrome)
  • physical obstacles that prevent Abdominal FES (e.g. severe abdominal trauma, pacemaker)
  • terminal illness
  • no response to Abdominal FES (e.g. lower motor neuron impairment)
  • recent abdominal surgery within four weeks prior to study inclusion
  • no clearly visible separate layers of the abdominal muscles (external oblique, internal oblique and transverse abdominal muscles), assessed with ultrasound during routine care

Outcomes

Primary Outcomes

Not specified

Similar Trials